Moderna Receives Refusal-to-File Letter from the U.S. Food and Drug Administration for Its Investigational Seasonal Influenza Vaccine, mRNA-1010

Refusal to review the submission is inconsistent with feedback at pre-Phase 3 and pre-submission consultations; Moderna ...
Axios on MSN

Copycat weight-loss drugs fuel fight between Trump and telehealth companies

An intensifying showdown over copycat GLP-1 weight-loss drugs is pitting the Trump administration and drug companies against ...

FDA clarifies rules for “no artificial colours” food packaging claims

The US Food and Drug Administration has issued a letter outlining how it will apply enforcement discretion to voluntary “no ...

House lawmaker raises new concerns over FDA's ultra-fast drug review program

A Democratic lawmaker is raising new concerns about a Food and Drug Administration program designed to drastically shorten ...
Everyday Health

FDA Loosens Rules for ‘No Artificial Colors’ Labeling on Food

The agency will no longer crack down on manufacturers that use natural dyes in foods labeled ‘No artificial colors.’ Here’s ...